相关实验视频

Updated: Jan 11, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

针对可切除肺癌的向治疗和手术之间的不断变化的相互作用

Victoria Yin¹, Mara B Antonoff²

¹Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA.

|November 13, 2025

概括

针对性疗法,如奥西默提尼布和阿莱克提尼布,当与手术一起使用时,可以改善可切除非小细胞肺癌 (NSCLC) 的存活率. 早期的分子分析是指导NSCLC患者治疗的关键.

科学领域:

在瘤学瘤学.
胸部外科手术胸部外科手术
分子向疗法分子向疗法

背景情况:

具有里程碑意义的试验正在为切除的非小细胞肺癌 (NSCLC) 与手术一起建立向治疗.
针对性药物的整合正在改变早期肺癌的治疗模式.

研究的目的:

审查目前针对可切除NSCLC的向治疗的临床证据.
突出针对性药物的不断变化的作用,与肺癌的手术切除相结合.

主要方法:

最近的临床试验和回顾性研究的叙述性综述.
综合数据,重点关注可切除NSCLC的向治疗疗效.

主要成果:

辅助性 osimertinib (EGFR 突变的 NSCLC) 和 alectinib (ALK 阳性 NSCLC) 显著改善了切割后的结果 (ADAURA,ALINA 试验).
新辅助剂奥西默蒂尼布在改善病理反应率和促进手术方面表现有前途 (NeoADAURA试验).
早期的分子分析对指导NSCLC治疗决策至关重要.

结论:

目前的数据支持针对性疗法作为手术切除NSCLC的多模式护理的组成部分.
目前正在进行的试验将进一步确定最佳时间,并扩大向治疗的使用范围,这可能会影响晚期疾病管理.

关键词:

辅助疗法是一种辅助疗法.亚莱克提尼布 (alectinib) 是一种药物.分子测试试验分子测试新辅助疗法是一种新辅助疗法.非小细胞肺癌的肺癌.奥西米尔丁尼布 (osimertinib) 是一种手术手术手术手术手术手术手术有针对性的治疗.氨酸激酶抑制剂氨酸激酶抑制剂

更多相关视频

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...